Am J Transplant, Volume 21, Suppl 3 Archives - Page 51 of 139 - ATC Abstracts

2021 American Transplant Congress
Improving Policy-constrained Kidney Exchange via Pre-screening
D. C. McElfresh¹, M. Curry², S. Booker³, M. Stuart³, D. Stewart³, R. Leishman³, T. Sandholm⁴, J. Dickerson²
¹Applied Mathematics, University of Maryland, College Park, MD, ²University of Maryland, College Park, MD, ³United Network for Organ Sharing, Richmond, VA, ⁴Carnegie Mellon University, Pittsburgh, PA
*Purpose: Many planned kidney exchange transplants do not go to transplantation (they “fail”) for a variety of reasons, such as positive crossmatch and logistical difficulties.…
2021 American Transplant Congress
Early Transplant Education Increases CKD 3-5 Patients’ Knowledge and Informed Decision-Making About Chronic Kidney Disease and Living Donor Kidney Transplant
A. D. Waterman¹, S. H. Kawakita², B. Dub³, Y. A. Iraheta¹, A. L. Murillo², T. Menser⁴, B. Mittman³
¹UCLA David Geffen School of Medicine, Los Angeles, CA, ²Terasaki Institute, Los Angeles, CA, ³Research and Evaluation, Kaiser Permanente, Pasadena, CA, ⁴The Houston Methodist Research Institute, Houston, CA
*Purpose: Early education about chronic kidney disease (CKD) and living donor kidney transplant (LDKT) outside of transplant centers is inconsistent, with patients in CKD 3…
2021 American Transplant Congress
Impact of Allosensitization on Xenotransplantation
D. Olaso¹, M. Manook¹, J. Yoon¹, Y. Bae¹, A. Barbas¹, A. Adams², S. Knechtle¹, J. Kwun¹
¹Department of Surgery, Duke Transplantation Center, Durham, NC, ²Department of Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Sensitization to human leukocyte antigens (HLA) due to prior exposure to foreign antigens through events such as blood transfusions, previous kidney transplant, or pregnancy…
2021 American Transplant Congress
Use of Donor Blood Expedites HCV Genotyping and Allows Earlier DAA Initiation for Recipients of HCV+ Kidneys
B. Lonze, N. Ali, R. Montgomery, Z. Stewart Lewis
Tranplant Institute, NYU Langone Health, New York, NY
*Purpose: Utilization of HCV viremic donor kidneys for transplant into HCV naïve recipients has become more widespread, yet best practices governing the initiation, timing or…
2021 American Transplant Congress
Successful Long Term Survival of Vascularized Composite Allografts After Extended Preservation at Subzero Temperatures Using Bioinspired Next Generation Cryoprotectants
M. Kline¹, S. Fidder², A. Callegari¹, A. Matoso², B. Oh², K. Lombardo², J. Etra², D. Vasilic³, A. Childs¹, R. Redett², G. Brandacher², X. Wei¹
¹X-Therma Inc., Richmond, CA, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Erasmus MC, Rotterdam, Netherlands
*Purpose: Vascularized composite allotransplantation (VCA) is a viable reconstructive option for patients with devastating tissue defects. However, the field is constrained by short tolerable ischemia…
2021 American Transplant Congress
Liver Transplantation for COVID-19-associated Cholangiopathy
J. Blondeel¹, P. Meersseman², N. Gilbo¹, I. Jochmans¹, M. Sainz-Barriga¹, J. Pirenne¹, D. Monbaliu¹
¹Abdominal Transplantation Surgery, University Hospitals Leuven, Leuven, Belgium, ²Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium
*Purpose: The hallmark viral pneumonia of coronavirus-19-disease (COVID-19) is often accompanied by important extra-pulmonary manifestations. Liver dysfunction occurs in up to 45% of COVID-19 patients,…
2021 American Transplant Congress
Prevalence of Hepatitis E Virus Infection in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis
P. Hansrivijit¹, A. Trongtorsak², B. Boonpheng³, C. Thongprayoon⁴, W. Cheungpasitporn⁴
¹Department of Internal Medicine, UPMC Pinnacle, Harrisburg, PA, ²Department of Internal Medicine, Amita Health Saint Francis Hospital, Evanston, IL, ³Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, CA, ⁴Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
*Purpose: Hepatitis E virus (HEV) infection is an underdiagnosed disease due to the use of serological assays with low sensitivity. Although most patients with HEV…
2021 American Transplant Congress
The Implementation of the New Unos Policy That Relegates C-peptide and Body Mass Index Criteria Has Resulted in Shifting Recipient Demographics
R. Teo, A. Rechnitzer, N. A. Muhdi, J. Torabi, M. Ajaimy, L. Liriano-Ward, Y. Azzi, C. Pynadath, P. Loarte-Campos, A. Brooks, J. P. Rocca, M. Le, E. Akalin, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Waitlist time accrual for SPK was previously limited to candidates on insulin that had either a c-peptide ≤ 2 ng/ml, or a c-peptide >…
2021 American Transplant Congress
The Efficacy of Delayed Fc-nonbinding Anti-CD3 Antibody Treatment in Sensitized Allogeneic Mouse Heart Transplantation
T. Ota¹, R. Goto¹, R. Kanazawa¹, K. Shibuya¹, Y. Ganchiku¹, N. Kawamura², M. Watanabe², M. Fukai¹, T. Shimamura³, A. Taketomi¹
¹Dept. of Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan, ²Dept. of Transplant Surgery, Hokkaido University, Sapporo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Delayed treatment with Fc-nonbinding anti-CD3 antibody (ab) permits early graft infiltrating cells to promotes a transplant tolerance. However, graft infiltrating cells immediate after transplantation…
2021 American Transplant Congress
Suppression of T Cell Proliferation by Activated Nonhuman Primate B Cells
K. Lee, K. Deng, G. Huai, F. Qiang, C. Rickert, J. Lei, C. Leguern, J. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: We previously generated Toll-like receptor (TLR)-activated B cells in rodent settings. These B cells can suppress T cell proliferation via in vitro mixed lymphocytes…